Paper · 4359489
Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus.
Cooper GM. Proc Natl Acad Sci U S A, 1973. Cited by 65 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus. Papers, record 4359489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4359489
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Deoxyribonucleosides | Major topic |
| Deoxyribonucleotides | Major topic |
| Simplexvirus | Major topic |
| Adult | |
| Animals | |
| Bromides | |
| Bromodeoxyuridine | |
| Carcinoma | |
| Carcinoma, Squamous Cell | |
| Cell Line | |
| Cell Transformation, Neoplastic | |
| Cricetinae | |
| DNA | |
| DNA, Neoplasm | |
| Deoxycytidine | |
| Deoxycytidine Monophosphate | |
| Female | |
| Humans | |
| Kidney | |
| Laryngeal Neoplasms | |
| Middle Aged | |
| Phosphorus | |
| Phosphotransferases | |
| Tritium | |
| Uterine Cervical Neoplasms | |
| Viral Plaque Assay |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,284,715 | Properties of deoxythymidine kinase partially purified from animal tumors. | J Biol Chem | 1965 | https://conductscience.org/library/papers/4284715 | PubMed |
| 2 | 5,216,626 | In vivo studies with antiviral agents. | Ann N Y Acad Sci | 1965 | https://conductscience.org/library/papers/5216626 | PubMed |
| 3 | 5,323,379 | Clinical experience with nucleosides in herpes simplex eye infections in man and animals. | Ann N Y Acad Sci | 1965 | https://conductscience.org/library/papers/5323379 | PubMed |
| 4 | 4,285,582 | Development of resistance to antiviral drugs. | Ann N Y Acad Sci | 1965 | https://conductscience.org/library/papers/4285582 | PubMed |
| 5 | 4,956,026 | Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity. | Biochem Pharmacol | 1965 | https://conductscience.org/library/papers/4956026 | PubMed |
| 6 | 4,161,091 | Cytology and histopathology of cervical herpes simplex infection. | Cancer | 1966 | https://conductscience.org/library/papers/4161091 | PubMed |
| 7 | 4,289,344 | A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus. | Virology | 1967 | https://conductscience.org/library/papers/4289344 | PubMed |
| 8 | 5,684,726 | Mammalian deoxynucleoside kinase. I. Deoxycytidine kinase: purification, properties, and kinetic studies with cytosine arabinoside. | J Biol Chem | 1968 | https://conductscience.org/library/papers/5684726 | PubMed |
| 9 | 4,972,143 | Studies of the enzymatic deamination of ara-cytidine. V. inhibition in vitro and in vivo by tetrahydrouridine and other reduced pyrimidine nucleosides. | Biochem Pharmacol | 1968 | https://conductscience.org/library/papers/4972143 | PubMed |
| 10 | 4,315,978 | Evidence for the induction of a new deoxycytidine kinase in cells infected with herpes virus. | Biochem J | 1970 | https://conductscience.org/library/papers/4315978 | PubMed |
1 to 10 of 27
See all 27 referencesCited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15,825,318 | Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15825318 | PubMed |
| 8,551,594 | Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside. | J Virol | 1996 | https://conductscience.org/library/papers/8551594 | PubMed |
| 6,303,214 | Incorporation of 5-substituted analogs of deoxycytidine into DNA of herpes simplex virus-infected or - transformed cells without deamination to the thymidine analog. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6303214 | PubMed |
| 6,291,452 | Capacity of deoxycytidine to selectively antagonize cytotoxicity of 5-halogenated analogs of deoxycytidine without loss of antiherpetic activity. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6291452 | PubMed |
| 6,289,324 | Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6289324 | PubMed |
| 6,262,539 | Tetrahydrouridine specifically facilitates deoxycytidine incorporation into herpes simplex virus DNA. | J Virol | 1981 | https://conductscience.org/library/papers/6262539 | PubMed |
| 6,258,155 | Expression of the herpes thymidine kinase gene in Xenopus laevis oocytes: an assay for the study of deletion mutants constructed in vitro. | Nucleic Acids Res | 1980 | https://conductscience.org/library/papers/6258155 | PubMed |
| 6,254,055 | Nucleosomal packaging of the thymidine kinase gene of herpes simplex virus transferred into mouse cells: an actively expressed single-copy gene. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6254055 | PubMed |
| 4,365,718 | Inhibition of herpes simplex virus type 2 replication by thymidine. | J Virol | 1974 | https://conductscience.org/library/papers/4365718 | PubMed |
| 3,010,836 | Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3010836 | PubMed |
1 to 10 of 19
See all 19 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4359489
GET https://conductscience.org/api/papers/v1/4359489/references?page=2